Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
US Treasury 10 Year Note ETF
UTEN
$266M
| $20.2M | ﹤0.01% |
468,060
-70,247
| -13% | -$3.04M |
|
|
PONY
3077
Pony AI Inc
PONY
$3.29B
| $20.2M | ﹤0.01% |
2,908,301
-295,643
| -9% | -$2.74M |
|
3078
RLJ Lodging Trust
RLJ
$1.75B
| $20.2M | ﹤0.01% |
1,703,931
+764,982
| +81% | +$7.16M |
|
|
PRSU
3079
Pursuit Attractions and Hospitality Inc
PRSU
$1.36B
| $20.2M | ﹤0.01% |
360,172
-88,396
| -20% | -$3.9M |
|
3080
Pennant Group
PNTG
$1.3B
| $20.1M | ﹤0.01% |
544,936
+12,653
| +2% | +$413K |
|
3081
PIMCO Municipal Income Opportunities Active ETF
MINO
$756M
| $20.1M | ﹤0.01% |
439,710
+336,739
| +327% | +$15.3M |
|
|
ORCL.PRD
3082
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $20.1M | ﹤0.01% |
449,213
-515,498
| -53% | -$27.7M |
|
3083
Astrana Health
ASTH
$1.88B
| $20.1M | ﹤0.01% |
433,508
+94,705
| +28% | +$3.41M |
|
3084
ProKidney
PROK
$382M
| $20.1M | ﹤0.01% |
9,854,178
+898,211
| +10% | +$1.64M |
|
3085
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$560M
| $20.1M | ﹤0.01% |
885,349
+36,365
| +4% | +$827K |
|
3086
Corvus Pharmaceuticals
CRVS
$1.19B
| $20.1M | ﹤0.01% |
1,344,736
-1,154,089
| -46% | -$16M |
|
3087
Frontline
FRO
$9.84B
| $20.1M | ﹤0.01% |
577,422
-514,050
| -47% | -$18.9M |
|
3088
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$332M
| $20.1M | ﹤0.01% |
750,805
+255,408
| +52% | +$6.69M |
|
|
CAM
3089
AB California Intermediate Municipal ETF
CAM
$1.21B
| $20.1M | ﹤0.01% |
798,103
+28,165
| +4% | +$705K |
|
3090
Cohen & Steers Closed End Opportunity Fund
FOF
$376M
| $20.1M | ﹤0.01% |
1,444,606
+17,778
| +1% | +$243K |
|
|
NPKI
3091
NPK International
NPKI
$1.12B
| $20M | ﹤0.01% |
1,259,432
-563,628
| -31% | -$8.5M |
|
3092
BioCryst Pharmaceuticals
BCRX
$2.51B
| $20M | ﹤0.01% |
1,999,684
-23,304
| -1% | -$211K |
|
3093
Sylvamo
SLVM
$1.45B
| $20M | ﹤0.01% |
528,782
-17,945
| -3% | -$728K |
|
3094
IDT Corp
IDT
$1.72B
| $20M | ﹤0.01% |
343,468
+108,807
| +46% | +$5.76M |
|
|
OPPJ
3095
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$283M
| $19.9M | ﹤0.01% |
345,945
+256,147
| +285% | +$14.8M |
|
3096
Goldman Sachs MarketBeta International Equity ETF
GSID
$1.11B
| $19.9M | ﹤0.01% |
265,455
+116,008
| +78% | +$8.62M |
|
3097
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
| $19.9M | ﹤0.01% |
860,284
-878
| -0.1% | -$20.3K |
|
3098
iShares Future Exponential Technologies ETF
XT
$3.96B
| $19.9M | ﹤0.01% |
240,445
+4,550
| +2% | +$355K |
|
|
GLO
3099
Clough Global Opportunities Fund
GLO
$247M
| $19.8M | ﹤0.01% |
3,236,910
-129,680
| -4% | -$764K |
|
3100
Lindsay Corp
LNN
$1.16B
| $19.8M | ﹤0.01% |
160,013
+33,087
| +26% | +$3.7M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.